Clinical Trials
Soterix Medical launches TDCS trial for cocaine dependancy
Soterix Medical introduced yesterday that it has gained a NIH-SBIR Section I contract with the Nationwide Institutes of Well...
Read more
FDA Approves First Feasibility Trials of Foldax's Tria Biopolymer Coronary heart Valve
Firm of cardiovascular gadgets on the early stage Foldax introduced at the moment that it has acquired FDA approval...
Read more
Titan Medical hopes FDA's T4 IDE take a look at shall be launched on the Sports activities Robotics platform
Robotic Surgical Platform Developer Titan Medical (NSDQ:TMDI) stated final night time that she hoped to launch an FDA exemption...
Read more
GI Dynamics Receives IRB Approval for US EndoBarrier Core Trial
GI Dynamics (ASX:GID) mentioned yesterday that it has obtained approval from the Institutional Evaluate Board to launch a pivotal...
Read more
The protection committee confirms the continuation of the endocarditis take a look at at CytoSorbents
CytoSorbants (OTC:CTSO) mentioned this week that the Knowledge Security Monitoring Board of its REMOVE trial had given the corporate...
Read more
Vectorious begins the implantable cardiac monitor check
Vector medical applied sciences mentioned that he had begun a primary human trial of his machine for monitoring left...
Read more
Research: Abbott's Mitraclip procedures present problems and low mortality charge
Regardless of the rise within the variety of procedures on account of ageing sufferers, minimally invasive mitral valve restore...
Read more
Biosense Webster from J & J launches a Qdot Micro RF RF accredited IDE ablation take a look at
Johnson & Johnson'S (NYSE:JNJ) Biosense Webster Yesterday, she launched a brand new FDA research on the exemption of her...
Read more
AtriCure launches a check to take away persistent atrial fibrillation CryoIce
AtriCure (NSDQ:ATRC) introduced at present that it has launched a brand new FDA-approved trial of its CryoIce machine to...
Read more
FDA: Preliminary information from the Abiomed Impella RP post-marketing research present a 17% survival price
The FDA mentioned yesterday that preliminary information from a post-approval research of Abiomed'S (NSDQ:BDMVThe Impella RP cardiac pump system...
Read more